From Department of Maternal-Fetal Medicine, Catholic University of the Sacred Heart, Rome, Italy (A.F., G.D.S., C.V., A.L., G.S.); Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Italy (M.M.); Fetal Medicine Unit, Saint George's Hospital, London, United Kingdom (A.K.); Pediatric Cardiology Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden (S.S.-E.); Department of Obstetrics and Gynecology, IRCCS San Martino Hospital University of Genoa, Italy (C.S.); Department of Obstetrics and Gynaecology, University of TorVergata, Rome, Italy (G.R.); Department of Medicine and Aging Sciences, University of Chieti-Pescara, Italy (M.E.F.); Department of Medical Sciences, University of Ferrara, Italy (L.M.); Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden (G.A.); and Department of Clinical Medicine, UiT- The Arctic University of Norway and Department of Obstetrics and Gynecology, University Hospital of Northern Norway, Tromsø (F.D.A.).
Circulation. 2017 Feb 21;135(8):772-785. doi: 10.1161/CIRCULATIONAHA.116.024068. Epub 2016 Dec 29.
Prenatal diagnosis of coarctation of the aorta (CoA) is still challenging and affected by high rates of false-positive diagnoses. The aim of this study was to ascertain the strength of association and to quantify the diagnostic accuracy of different ultrasound signs in predicting CoA prenatally.
Medline, Embase, CINAHL, and Cochrane databases were searched. Random-effects and hierarchical summary receiver operating characteristic model meta-analyses were used to analyze the data.
Seven hundred ninety-four articles were identified, and 12 (922 fetuses at risk for CoA) articles were included. Mean mitral valve diameter score was lower (<0.001) and the mean tricuspid valve diameter score was higher in fetuses with CoA than in those without CoA (=0.01). Mean aortic valve diameter score was lower in fetuses with CoA than in healthy fetuses (≤0.001), but the ascending aorta diameter, expressed as score or millimeters, was similar between groups (=0.07 and 0.47, respectively). Mean aortic isthmus diameter scores measured either in sagittal (=0.02) or in 3-vessel trachea view (<0.001) were lower in fetuses with CoA. Conversely, the mean pulmonary artery diameter score, the right/left ventricular and pulmonary artery/ascending aorta diameter ratios were higher (<0.001, =0.02, and =0.02, respectively) in fetuses with CoA in comparison with controls, although aortic isthmus/arterial duct diameter ratio was lower in fetuses with CoA than in those without CoA (<0.001). The presence of coarctation shelf and aortic arch hypoplasia were more common in fetuses with CoA than in controls (odds ratio, 26.0; 95% confidence interval, 4.42-153; <0.001 and odds ratio, 38.2; 95% confidence interval, 3.01-486; =0.005), whereas persistent left superior vena cava (=0.85), ventricular septal defect (=0.12), and bicuspid aortic valve (=0.14) did not carry an increased risk for this anomaly. Multiparametric diagnostic models integrating different ultrasound signs for the detection of CoA were associated with an increased detection rate.
The detection rate of CoA may improve when a multiple-criteria prediction model is adopted. Further large multicenter studies sharing the same imaging protocols are needed to develop objective models for risk assessment in these fetuses.
主动脉缩窄(CoA)的产前诊断仍然具有挑战性,并且存在较高的假阳性诊断率。本研究旨在确定不同超声征象预测 CoA 的关联强度和诊断准确性。
检索了 Medline、Embase、CINAHL 和 Cochrane 数据库。采用随机效应和分层综合接收者操作特征模型荟萃分析来分析数据。
共确定了 794 篇文章,纳入了 12 篇(922 例有 CoA 风险的胎儿)文章。CoA 胎儿的二尖瓣直径评分较低(<0.001),三尖瓣直径评分较高(=0.01)。CoA 胎儿的主动脉瓣直径评分低于健康胎儿(≤0.001),但升主动脉直径,以 评分或毫米表示,两组间相似(=0.07 和 0.47)。CoA 胎儿的主动脉峡部直径评分在矢状位(=0.02)或 3 血管气管视图(<0.001)中较低。相反,CoA 胎儿的肺动脉直径评分、右/左心室和肺动脉/升主动脉直径比值较高(<0.001、=0.02 和=0.02),尽管 CoA 胎儿的主动脉峡部/动脉导管直径比值低于无 CoA 胎儿(<0.001)。CoA 胎儿中存在缩窄架和主动脉弓发育不良的比例高于对照组(比值比,26.0;95%置信区间,4.42-153;<0.001 和比值比,38.2;95%置信区间,3.01-486;=0.005),而永存左上腔静脉(=0.85)、室间隔缺损(=0.12)和二叶主动脉瓣(=0.14)不增加这种异常的风险。纳入不同超声征象的多参数诊断模型用于检测 CoA 可提高检出率。需要进一步开展大型多中心研究,共享相同的成像方案,为这些胎儿的风险评估制定客观模型。